Drugs Made In America Acquisition Corp. (DMAA)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
10. 67
+0.02
+0.1878%
$
359.42M Market Cap
- P/E Ratio
- Div Yield
800 Volume
- Eps
$ 10.65
Previous Close Want to track DMAA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Drugs Made In America Acquisition Corp. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Daniel L. Lippincott Karpus Management Inc. | 2.53M | $25.43M | $26.99M | $1.56M | 6.12% |
| SK Steven Katznelson Radcliffe Capital Management LP | 546,808 | $5.61M | $5.83M | $222,895.77 | 3.97% |
| BO Brian Oliveira Clear Street Group Inc. | 354,048 | $3.65M | $3.78M | $122,312.32 | 3.35% |
